Party Secretary of Shaoxing Municipal Party Committee visited Zhejiang Nano antibody production base and Zhejiang Cell Therapy Group for investigation and investigation

Photo: Party Secretary of Shaoxing visited Zhejiang Cell Therapy Group

On February 10, accompanied by Xu Jianjian, Party Secretary of Shengzhou, Qiu Jianyong, Mayor of Shengzhou, Qian Qijun, Chairman of Shanghai Cell Therapy Group and Ding Na, president of Shengzhou Cell Therapy Group, Zhejiang Shaoxing Municipal Party Committee Secretary Sheng Yuechun, Mayor Shi Huifang, People's Congress Director Tan Zhigui, CPPCC Chairman Wei Wei and other four sets of teams, as well as the main party and government leaders of each district and county visited the Zhejiang Nano Antibody and Zhejiang Cell Therapy Group under Shanghai Cell Therapy Group for investigation and investigation. Add new impetus to the development of Zhejiang Nano Antibody production base and Zhejiang Cell Therapy Group into an internationally influential research and development and production base of key raw materials for cell and gene therapy.

Photo: The delegation visited the alpaca breeding demonstration base in Shengzhou, Zhejiang province, where nano-antibodies were investigated

On the same day, the delegation visited the Shengzhou alpaca breeding demonstration base of Zhejiang nano-antibody. The infrastructure of the breeding base has been gradually improved. Zhejiang Nano Antibody has introduced a large number of alpacas from Chile. In the future, more Alpaca, Llama, bactrian and dromedary camels will be bred, and more and more imported alpacas will be settled here. Field, introduce to the delegation from qi-jun qian, nano antibody as a single domain antibodies, drug in cells and antibodies to the research and development plays a very important value, in addition to shengzhou build large camel species breeding base, we set up r&d center in Shanghai, San Francisco, circulate in the domestic, for nuclear, international circulation fu can nano antibody innovation research activity, Promote industrial innovation through both internal and external circulation. Zhejiang nano antibody combined with the advantages of artificial intelligence, through artificial intelligence optimization design of the nano antibody compared with the existing traditional antibody drug, has a high affinity, high stability, low immunogenicity, strong penetrating power and soluble good advantages, such as can have more widely used in clinical treatment and better clinical curative effect.

As one of the key layouts of Shanghai Cell Therapy Group, Zhejiang Cell Therapy Group always adheres to source innovation and focuses on the industrial supply of raw materials for cell drug engineering. Zhejiang Cell Therapy Group is committed to the development and production of "stuck" raw materials, mRNA raw materials and mRNA production system in gene and cell therapy. According to the leaders of the research group, mRNA drugs, as innovative drugs in the field of biomedicine, have great prospects for development. Zhejiang nano antibody is worth looking forward to both in terms of cost and development value.

With the help of policy guidance and capital empowerment, Shanghai Cell Therapy Group has built a good industrial development environment and industrial chain ecology in just a few years, attracting more and more capital attention. Based on the accumulation of many technological breakthroughs in 2021, especially the underlying "bottleneck" technology and logic breakthrough, the group will create truly valuable innovative products in 2022, accelerate the product conversion and internationalization process, let more people enjoy advanced medical treatment, and promote the cell therapy industry to climb to a new peak.

Photo: Party Secretary of Shaoxing visited Zhejiang Cell Therapy Group

Photo: The delegation visited the alpaca breeding demonstration base in Shengzhou, Zhejiang province, where nano-antibodies were investigated